One of the effective mechanisms for reducing the development of pathologies at menopauseis the search for significant alternative means of reducing the severity of menopausalmanifestations. In order to identify the correction of the severity of climacteric symptomsa study of 154 patients was conducted, the patients were divided into three groups: 53 womenat natural menopause, 50 women at surgical menopause, the same patients (n = 53 and n = 50)6 months after taking flaxseed oil and 51 control patients.Thus, it was found out that operated women develop more often extragenital pathologyand more frequently consult medical specialists than those at natural menopause and healthyparticipants. Comorbidity in the main groups is more than two nosologies with a predominanceof arterial hypertension. According to the Green scale menopausal severesymptoms in femalepatients with oophorectomy and moderate biological menopause symptoms of vasomotor and emotional-mental statusare leading. After daily use of flaxseed oil in operated womenand those at natural menopause the severity of menopausal symptoms decreased equalingmoderate and mild severity, respectively, along with the frequency of patients’visitsto specialists to a greater extent in patients at natural menopause. The effectivenessof taking flaxseed oil by women at surgical or natural menopause for menopausal disordersof varying severity makes it possible to use it as an alternative for correction duringthe period of estrogen deficiency.
- 1. Васильев, А. П. Омега-3-жирные кислоты в кардиологической практике/ А. П. Васильев, Н. Н. Стрельцова // Consilium Medicum. – 2017. – № 19 (10). – С. 96–104.
- 2. Кузнецова, И. В. Выбор между гормональной и альтернативной терапией в периоде менопаузального перехода и постменопаузе / И. В. Кузнецова // РМЖ. – 2018. – № 2(I). – С. 43–47.
- 3. Ощепкова, С. Ю. Хирургическая менопауза. Важные аспекты течения и лечения / С. Ю. Ощеп-кова, И. П. Зязева // Международный студенческий научный вестник. – 2020. – № 5. – С. 2.
- 4. Шабалова, О. В. Хирургическая менопауза как фактор риска раннего развития коморбидных состояний у женщин репродуктивного возраста/ О. В. Шабалова [и др.] // Акушерство и гинекология. – 2021. – № 6. – С. 54–59.
- 5. Charlson, M. E. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation /M. E. Charlson, P. Pompei, K. L. Ales, C. R. McKenzie // J. Chron Dis. – 1987. – Vol. 40(5). – Р. 373–383.
- 6. Greene, J. G. Climacteric Scale (GCS) / J. G. Green // Constructing a standard climacteric scale. Maturitas. – 1998. – Vol. 29. – Р. 25–31.
- 7. Saravanan, P. Cardiovascular effects of marine omega-3 fatty acids / P. Saravanan, N. C. Davidson, E. B. Schmidt, P. C. Calder // Lancet. 2010. – Vоl. 375. – P. 540–550.
- 8. Virani, S. S. Heart Disease and Stroke Statistics-2020 update: А report from the American Heart Association / S. S. Virani [et al.] // Circulation. – 2020. – Vol. 141, № 9. – P. e139–e596.